Industry and FDA can—and must—do more to protect global pharmaceutical supply chains
Alan Coukell, Pew Prescription Project
Advertisement
Articles by Alan Coukell, Pew Prescription Project
Advertisement
Latest Updated Articles
- After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs
Published: August 28th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
3
A 'Beautiful Fake': Pharma Fraudsters Upping Their Game
4
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
5
